326 related articles for article (PubMed ID: 17352682)
21. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
Lin K; Cai Z; Wang F; Zhang W; Zhou W
Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Yazbeck R; Howarth GS; Abbott CA
Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
[TBL] [Abstract][Full Text] [Related]
23. Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.
Turdu G; Gao H; Jiang Y; Kabas M
Future Med Chem; 2018 May; 10(10):1229-1239. PubMed ID: 29749760
[TBL] [Abstract][Full Text] [Related]
24. Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability.
Méndez LR; Arrebola Y; Valdés-Tresanco ME; Díaz-Guevara L; Bergado G; Sánchez B; Charli JL; Pascual Alonso I
Int J Biol Macromol; 2020 Dec; 164():2944-2952. PubMed ID: 32846184
[TBL] [Abstract][Full Text] [Related]
25. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
26. Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling.
Zhang X; Wang J; Su M; Li Z; Li J; Li J; Liu H
Chem Biol Drug Des; 2012 Dec; 80(6):843-52. PubMed ID: 22726613
[TBL] [Abstract][Full Text] [Related]
27. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
Zhang H; Chen Y; Keane FM; Gorrell MD
Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.
Augustyns K; Van der Veken P; Senten K; Haemers A
Curr Med Chem; 2005; 12(8):971-98. PubMed ID: 15853709
[TBL] [Abstract][Full Text] [Related]
29. Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects.
Nagatsu T
J Neural Transm (Vienna); 2017 Jun; 124(6):739-744. PubMed ID: 27503084
[TBL] [Abstract][Full Text] [Related]
30. Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin.
Benramdane S; De Loose J; Filippi N; Espadinha M; Beyens O; Rymenant YV; Dirkx L; Bozdag M; Feijens PB; Augustyns K; Caljon G; De Winter H; De Meester I; Van der Veken P
J Med Chem; 2023 Sep; 66(18):12717-12738. PubMed ID: 37721854
[TBL] [Abstract][Full Text] [Related]
31. The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.
Waumans Y; Baerts L; Kehoe K; Lambeir AM; De Meester I
Front Immunol; 2015; 6():387. PubMed ID: 26300881
[TBL] [Abstract][Full Text] [Related]
32. Active site-directed probes targeting dipeptidyl peptidases 8 and 9.
Espadinha M; De Loose J; Corthaut S; Thys S; Van Rymenant Y; Verhulst E; Benramdane S; Filippi N; Augustyns K; Van Wielendaele P; Pintelon I; De Meester I; Van der Veken P
Eur J Med Chem; 2024 Apr; 270():116389. PubMed ID: 38593588
[TBL] [Abstract][Full Text] [Related]
33. Sixteen-years of clinically relevant dipeptidyl peptidase-IV (DPP-IV) inhibitors for treatment of type-2 diabetes: a perspective.
Kushwaha RN; Haq W; Katti SB
Curr Med Chem; 2014; 21(35):4013-45. PubMed ID: 25245373
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.
Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ
Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192
[TBL] [Abstract][Full Text] [Related]
35. Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer.
De S; Banerjee S; Kumar SKA; Paira P
Mini Rev Med Chem; 2019; 19(2):88-97. PubMed ID: 29692250
[TBL] [Abstract][Full Text] [Related]
36. Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.
Demuth HU; Schlenzig D; Schierhorn A; Grosche G; Chapot-Chartier MP; Gripon JC
FEBS Lett; 1993 Mar; 320(1):23-7. PubMed ID: 8096464
[TBL] [Abstract][Full Text] [Related]
37. 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV.
Tsu H; Chen X; Chen CT; Lee SJ; Chang CN; Kao KH; Coumar MS; Yeh YT; Chien CH; Wang HS; Lin KT; Chang YY; Wu SH; Chen YS; Lu IL; Wu SY; Tsai TY; Chen WC; Hsieh HP; Chao YS; Jiaang WT
J Med Chem; 2006 Jan; 49(1):373-80. PubMed ID: 16392822
[TBL] [Abstract][Full Text] [Related]
38. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8.
Abbott CA; Yu DM; Woollatt E; Sutherland GR; McCaughan GW; Gorrell MD
Eur J Biochem; 2000 Oct; 267(20):6140-50. PubMed ID: 11012666
[TBL] [Abstract][Full Text] [Related]
39. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
40. Molecular recognition of ligands in dipeptidyl peptidase IV.
Kuhn B; Hennig M; Mattei P
Curr Top Med Chem; 2007; 7(6):609-19. PubMed ID: 17352681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
